PROTOKINETIX BLOG

Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Jan 22, 2021

byprotokinetixp

Benefits of AAGP® | biotechnology investments | Type 1 Diabetes

Why Dr. Asim Raja believes in the potential of AAGP

Imagine the ability to fully recover from Type 1 diabetes and no longer live your life according to insulin. Imagine a future where we can overcome blindness. AAGP, the glycopeptide...Read more

Oct 30, 2020

byprotokinetixp

AAGP® | biotechnology | biotechnology investments | dry-eye | market opportunity

Biotech Investing: How to Pick a Winner

The promise of biotechnology stocks to the average investor is the potential for blazing growth and incredible returns. But not every company pays dividends on that promise. Too many times,...Read more

Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.